Ashby J., Houthoff E., Kennedy SJ, Stevens J., Bars R., Jekat F., Campbell P., Van Miller J, Carpanini FM, Randall Glp (1997). The challenge posed by endocrine-disrupting chemicals . Environ Health Perspect105: 164-169.
2.
Ashby J., Lefevre PA, Odum J., Tinwell H., Kennedy SJ, Beresford N., Sumpter JP (1997). Failure to confirm rodent uterotrophic activity for benzoic acid or clofibrate: Implication for lists of endocrine disrupting agents. Regul Toxicol Pharmacol26: 96-101.
3.
Bliley R. (1996). Food Quality Protection Act of 1996, 104th Congress, 2nd Session. Report 104-669, Part 2, Government Printing Office, Washington, DC.
4.
Kennedy SJ (1998). Environmental Oestrogens—An Industry Viewpoint. Hormonally Active Agents in Food. WILEY-VCH, Verlag GmbH, Weinheim, Germany.
5.
O'Connor JC, Cook JC, Craven SC, Van Pelt CS, Obourn JD (1996). An in vivo battery for identifying endocrine modulators that are estrogenic or dopamine regulators. Fundam Appl Toxicol33: 182-195.
6.
Odum J., Lefevre PA, Tittensor S., Paton D., Routledge EJ, Beresford NA, Sumpter JP, Ashby J. (1997). The rodent uterotrophic assay: Critical protocol features, studies with nonyl phenols, and comparison with a yeast estrogenicity assay. Regul Toxicol Pharmacol25: 176-188.
7.
Reel JR, Lamb JC. Neal BH (1996). Survey and assessment of mammalian estrogen biological assays for hazard characterisation. Fundam Appl Toxicol34: 288-305.
8.
Wakeling AE, Dukes M., Bowler J. (1991). A potent pure antioestrogen with clinical potential . Cancer Res51: 3867-3873.
